Congress Must Clarify FDA Oversight On Compounding: GAO

Congress Must Clarify FDA Oversight On Compounding: GAO

Lawmakers must resolve the lingering uncertainty about what oversight authority the U.S. Food and Drug Administration has over the controversial drug compounding industry in the wake of a fatal meningitis outbreak in 2012 caused by contaminated compounded ...read more

  • Tags: